Search
SOLACI Congress
HomePeripheral vascular diseaseRenal

Renal

View Category

Coronary disease

Simplified Rapid Intravenous Hydration for the Prevention of Contrast-Induced Nephropathy in Patients with Chronic Kidney Disease

Patients with chronic kidney disease (CKD) undergoing coronary angiography are at increased risk of developing contrast-associated acute...
solaci -
Learn More
Peripheral Vascular Disease

EuroPCR 2023 | New Renal Denervation Devices Show Promising Results

The Netrod System study included 205 patients with uncontrolled essential hypertension while taking two drugs (nifedipine and hydrochlorothiazide),...
solaci -
Learn More
Peripheral Vascular Disease

EuroPCR 2023 | More Evidence in Favor of Renal Denervation

This study included 219 patients with uncontrolled essential hypertension who had received at least two antihypertensive drugs. All...
solaci -
Learn More
Acute coronary syndromes

Is There Any Difference in Clinical Outcomes Between Transient and Persistent Acute Kidney Injury in ACS Patients after Invasive Treatment?

Acute kidney injury (AKI) following acute coronary syndrome (ACS) is associated with prolonged hospital stay and worse...
solaci -
Learn More
Peripheral vascular disease

TEATE Trial: Urine Alkalinization as a Target to Prevent Contrast-Associated Kidney Injury

Acute kidney injury related to iodinated contrast significantly increases morbidity and mortality after angiography or angioplasty. According...
solaci -
Learn More
Peripheral Vascular Disease

SYMPLICITY HTN-3 Trial. Evolution at 3 Years

The SYMPLICITY 3-year outcomes are out. Bear in mind this is the largest study we have had...
solaci -
Learn More
Peripheral vascular disease

TCT 2022 | RADIANCE II Pivotal Trial

Renal denervation has been developed to treat blood hypertension. Even though at present is still not common,...
solaci -
Learn More
Acute coronary syndromes

Gender Differences and 10-Year Prognosis in STEMI

Coronary artery disease in women usually develops 10 years later than in men, and some evidence suggests...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Dr. Omar Tupayachi - 0
Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Dr. Juan Manuel Pérez - 0
Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Dr. Juan Manuel Pérez - 0
Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Institutional News

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

solaci - 0
Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

solaci - 0
The Latin American Society of Interventional Cardiology invites you to participate in a new virtual scientific event titled “Pulmonary Embolism (PE) in 2025: Risk...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy